Crossmark

Response to the letter to the editor: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome patients: a single-center retrospective study

Crossref DOI link: https://doi.org/10.1007/s10067-024-07198-7

Published Online: 2024-10-29

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koc, Emine Rabia https://orcid.org/0000-0002-0264-7284
Güllü, Gizem https://orcid.org/0000-0001-9477-5031
Saridas, Furkan https://orcid.org/0000-0001-5945-2317
Gluscevic, Sanja https://orcid.org/0000-0002-9230-9093
Coskun, Belkıs https://orcid.org/0000-0003-0298-4157
Pehlivan, Yavuz https://orcid.org/0000-0002-1201-8836
Calikusu, Fatma Zehra https://orcid.org/0000-0002-6644-6553
Turan, Omer Faruk https://orcid.org/0000-0002-6752-1519
License Information

Text and Data Mining valid from 2024-10-29

Version of Record valid from 2024-10-29
More Information

Article History

Received: 15 October 2024

Revised: 15 October 2024

Accepted: 16 October 2024

First Online: 29 October 2024

Compliance with ethical standards

:

: None.

Document is current

Any future updates will be listed below